The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ELUCIREM and VUEWAY Guerbet Australia Pty Ltd
Product name
ELUCIREM and VUEWAY
Sponsor
Accepted date
Apr-2024
Active ingredients
gadopiclenol
Proposed indication
Indicated for contrast-enhanced magnetic resonance imaging (MRI) to detect and visualise lesions with abnormal blood brain barrier or abnormal vascularity.
Application type
A (new medicine)
Publication date
Apr-2024